Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
Rigouts L, Coeck N, Gumusboga M, de Rijk WB, Aung KJ, Hossain MA, Fissette K, Rieder HL, Meehan CJ, de Jong BC, Van Deun A.
Rigouts L, et al.
J Antimicrob Chemother. 2016 Feb;71(2):314-23. doi: 10.1093/jac/dkv360. Epub 2015 Nov 24.
J Antimicrob Chemother. 2016.
PMID: 26604243
Free PMC article.